AZN Oct 2024 70.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 03:43PM EDT. Market open.
Loading interactive chart…
- Yahoo Finance
AstraZeneca CFO: 'We've come a long way in our oncology portfolio'
AstraZeneca is beginning to see momentum behind its oncology portfolio. CFO Aradhana Sarin says the work is only just beginning.
- Zacks
FDA Expands AstraZeneca's (AZN) Farxiga Label in Pediatric T2D
Following the label expansion, AstraZeneca's (AZN) Farxiga is now approved to improve glycemic control in patients aged 10 years and older with T2D. It was previously approved for such use in adults.
- Investor's Business Daily
Why It's A New Day For COPD Patients — And Regeneron, Sanofi, Verona Stocks
There hasn't been a new COPD treatment in years. But Regeneron stock analysts are closely watching a pair of key FDA decisions.
© 2024 Yahoo. All rights reserved.